Total Payments
$6,908
2024 Payments
$1,049
Companies
34
Transactions
354
Medicare Patients
5,589
Medicare Billing
$456,700
Payment Breakdown by Category
Food & Beverage$6,879 (99.6%)
Education$29.18 (0.4%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,879 | 350 | 99.6% |
| Education | $29.18 | 4 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $1,117 | 33 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $941.78 | 61 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $806.53 | 29 | $0 (2024) |
| GlaxoSmithKline, LLC. | $654.94 | 38 | $0 (2024) |
| Lilly USA, LLC | $579.69 | 36 | $0 (2024) |
| Novo Nordisk Inc | $488.15 | 29 | $0 (2024) |
| PFIZER INC. | $435.55 | 26 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $298.38 | 20 | $0 (2021) |
| Novartis Pharmaceuticals Corporation | $244.95 | 13 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $192.98 | 5 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,049 | 37 | Amgen Inc. ($506.31) |
| 2023 | $1,016 | 45 | Janssen Pharmaceuticals, Inc ($290.37) |
| 2022 | $775.71 | 41 | GlaxoSmithKline, LLC. ($132.92) |
| 2021 | $1,193 | 69 | Janssen Pharmaceuticals, Inc ($194.00) |
| 2020 | $382.54 | 23 | PFIZER INC. ($103.14) |
| 2019 | $650.94 | 36 | AstraZeneca Pharmaceuticals LP ($155.13) |
| 2018 | $786.97 | 49 | AstraZeneca Pharmaceuticals LP ($291.88) |
| 2017 | $1,054 | 54 | Amgen Inc. ($191.69) |
All Payment Transactions
354 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $16.12 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 12/10/2024 | Lilly USA, LLC | EBGLYSS (Drug) | Food and Beverage | In-kind items and services | $32.35 | General |
| Category: Immunology | ||||||
| 11/21/2024 | ConvaTec Inc. | INNOVAMATRIX AC (Device) | Food and Beverage | In-kind items and services | $13.74 | General |
| Category: ADVANCED WOUND CARE | ||||||
| 11/20/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.35 | General |
| Category: Respiratory | ||||||
| 10/30/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $13.96 | General |
| Category: Respiratory | ||||||
| 10/29/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.43 | General |
| Category: Diabetes | ||||||
| 10/24/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $20.39 | General |
| Category: RESPIRATORY | ||||||
| 09/30/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.61 | General |
| Category: Inflammation | ||||||
| 09/24/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $18.98 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/12/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $22.68 | General |
| Category: RESPIRATORY | ||||||
| 09/05/2024 | Lilly USA, LLC | — | Food and Beverage | In-kind items and services | $13.30 | General |
| 09/03/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $23.18 | General |
| Category: Inflammation | ||||||
| 08/20/2024 | ConvaTec Inc. | INNOVAMATRIX AC (Device) | Food and Beverage | In-kind items and services | $14.54 | General |
| Category: ADVANCED WOUND CARE | ||||||
| 07/25/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $26.67 | General |
| 07/11/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $16.74 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 06/20/2024 | ConvaTec Inc. | INNOVAMATRIX AC (Device) | Food and Beverage | In-kind items and services | $16.49 | General |
| Category: ADVANCED WOUND CARE | ||||||
| 06/18/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.44 | General |
| Category: Respiratory | ||||||
| 06/05/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $135.76 | General |
| Category: Cardiology | ||||||
| 05/23/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $27.68 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/16/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $132.76 | General |
| Category: Cardiology | ||||||
| 05/15/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $13.27 | General |
| Category: Diabetes | ||||||
| 05/14/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $22.42 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/07/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $17.56 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 04/23/2024 | Xeris Pharmaceuticals, Inc. | KEVEYIS (Drug) | Food and Beverage | In-kind items and services | $16.75 | General |
| Category: Carbonic anhydrase inhibitor | ||||||
| 04/23/2024 | Xeris Pharmaceuticals, Inc. | KEVEYIS (Drug) | Food and Beverage | In-kind items and services | $16.63 | General |
| Category: Carbonic anhydrase inhibitor | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 1,350 | 1,948 | $303,447 | $112,069 |
| 2022 | 23 | 1,286 | 1,938 | $306,799 | $111,069 |
| 2021 | 18 | 1,408 | 1,977 | $312,253 | $119,773 |
| 2020 | 26 | 1,545 | 2,432 | $297,949 | $113,790 |
Total Patients
5,589
Total Services
8,295
Medicare Billing
$456,700
Procedure Codes
86
All Medicare Procedures & Services
86 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 220 | 474 | $175,650 | $57,695 | 32.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 141 | 141 | $37,581 | $18,299 | 48.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 104 | 126 | $33,324 | $12,601 | 37.8% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 22 | 24 | $13,679 | $5,362 | 39.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 23 | 23 | $10,542 | $2,939 | 27.9% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 132 | 132 | $4,989 | $2,426 | 48.6% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 25 | 25 | $4,288 | $1,815 | 42.3% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 100 | 131 | $3,508 | $1,719 | 49.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 119 | 189 | $3,239 | $1,588 | 49.0% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 68 | 87 | $2,923 | $1,432 | 49.0% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 105 | 133 | $2,809 | $1,377 | 49.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 14 | 111 | $3,426 | $1,171 | 34.2% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 107 | 134 | $2,082 | $1,020 | 49.0% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 32 | 65 | $1,262 | $618.80 | 49.0% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2023 | 56 | 68 | $1,227 | $601.12 | 49.0% |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | Office | 2023 | 28 | 28 | $1,081 | $529.76 | 49.0% |
| 82306 | Vitamin d-3 level | Office | 2023 | 16 | 17 | $1,006 | $493.17 | 49.0% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2023 | 16 | 16 | $588.48 | $288.32 | 49.0% |
| 96127 | Assessment of emotional or behavioral problems | Office | 2023 | 22 | 24 | $240.96 | $94.56 | 39.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 211 | 574 | $217,435 | $71,904 | 33.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 135 | 135 | $36,694 | $18,069 | 49.2% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 125 | 125 | $4,751 | $2,340 | 49.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 18 | 18 | $8,419 | $2,318 | 27.5% |
| 99495 | Transitional care management services for problem of moderate complexity | Office | 2022 | 13 | 13 | $5,584 | $2,194 | 39.3% |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | Office | 2022 | 21 | 28 | $4,200 | $2,093 | 49.8% |
About Dr. Luis Cardentey, M.D
Dr. Luis Cardentey, M.D is a Adult Medicine healthcare provider based in Fort Myers, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/29/2011. The National Provider Identifier (NPI) number assigned to this provider is 1457640666.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Luis Cardentey, M.D has received a total of $6,908 in payments from pharmaceutical and medical device companies, with $1,049 received in 2024. These payments were reported across 354 transactions from 34 companies. The most common payment nature is "Food and Beverage" ($6,879).
As a Medicare-enrolled provider, Cardentey has provided services to 5,589 Medicare beneficiaries, totaling 8,295 services with total Medicare billing of $456,700. Data is available for 4 years (2020–2023), covering 86 distinct procedure/service records.
Ad
Practice Information
- Specialty Adult Medicine
- Other Specialties Family Medicine
- Location Fort Myers, FL
- Active Since 03/29/2011
- Last Updated 02/06/2024
- Taxonomy Code 207QA0505X
- Entity Type Individual
- NPI Number 1457640666
Products in Payments
- XARELTO (Drug) $775.00
- FARXIGA (Drug) $751.62
- Repatha (Biological) $708.72
- TRELEGY ELLIPTA (Drug) $497.40
- Otezla (Drug) $330.26
- JARDIANCE (Drug) $319.60
- TRULICITY (Drug) $272.13
- Ozempic (Drug) $193.27
- Victoza (Drug) $151.61
- ENTRESTO (Drug) $146.19
- NEXLETOL (Drug) $139.36
- CHANTIX (Drug) $130.59
- PRALUENT ALIROCUMAB INJECTION (Biological) $124.99
- VRAYLAR (Drug) $116.72
- PRALUENT (Drug) $116.28
- ANORO ELLIPTA (Drug) $100.40
- LEQVIO (Drug) $98.76
- MOUNJARO (Drug) $94.58
- BREZTRI (Drug) $86.02
- ELIQUIS (Drug) $74.23
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.